Publication | Closed Access

Urotensin Inhibition with Palosuran Could Be a Promising Alternative in Pulmonary Arterial Hypertension

HypertensionUrologyPulmonary Arterial HypertensionCardiovascular DiseaseMedicineDrug DiscoveryAntihypertensive TherapyCardiovascular PharmacologyUrotensin InhibitionVascular BiologyPharmacotherapyPublic HealthPharmacologyPulmonary Vascular DiseasePalosuran Could